Phenominer Database Results (38 results)

 
 
Table "column sort" updates the order of the bars in the chart.
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Value Units SEM SD Method Method Duration Post Insult Type Post Insult Time Value Post Insult Time Unit Record ID Study ID
MW body weight right nephrectomy (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 6 258.7 g 11.0 26.94 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100799 2523
MW body weight right nephrectomy (for 84 days) then enalapril (20 mg/kg/d) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 299.6 g 11.7 35.1 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100823 2523
MW body weight right nephrectomy (for 84 days) then lisinopril (10 mg/kg/d) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 293.5 g 5.4 17.08 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100824 2523
MW body weight right nephrectomy (for 84 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 6 294.0 g 8.2 20.09 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100806 2523
MW body weight right nephrectomy (for 56 days) then reserpine (5 mg/l) and hydralazine (80 mg/l) and controlled hydralazine content drinking water (25 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 276.6 g 7.4 23.4 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100800 2523
MW body weight unilateral nephrectomy (for 14 days) then vehicle control condition Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 220.0 g 9.0 23.81 body measuring method 0.0 unx 14 days 101142 2581
MW body weight doxorubicin (2 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 215.0 g 9.0 23.81 body measuring method 0.0 doxorubicin 0 days 101144 2581
MW body weight unilateral nephrectomy (for 70 days) and captopril (500 mg/l) (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 5 234.0 g 17.0 38.01 body measuring method 0.0 unx 70 days 101155 2581
MW body weight control condition Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 18 362.0 g 14.0 59.4 body measuring method 0.0 control 29 days 101157 2581
MW body weight nephrectomy (for 28 days) then reserpine (5 mg/l) (for 21 days) and hydralazine (80 mg/l) (for 21 days) and controlled hydralazine content drinking water (25 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. body mass male 0 days 8 233.0 g 4.0 11.31 body weighing method 0.0 5/6 nephrectomy 28 days 100985 2561
MW body weight right nephrectomy (for 84 days) then captopril (30 mg/kg/d) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 290.8 g 8.0 25.3 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100822 2523
MW body weight right nephrectomy (for 84 days) then angiotensin II receptor antagonist (80 mg/l) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 5 276.4 g 4.9 10.96 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100826 2523
MW body weight right nephrectomy (for 112 days) then enalapril (20 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 313.8 g 15.0 45.0 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100830 2523
MW body weight right nephrectomy (for 56 days) then captopril (30 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 287.2 g 5.4 17.08 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100801 2523
MW body weight unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 5 207.0 g 17.0 38.01 body measuring method 0.0 unx 42 days 101147 2581
MW body weight control condition Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 18 332.0 g 14.0 59.4 body measuring method 0.0 control 17 days 101152 2581
MW body weight right nephrectomy (for 84 days) then reserpine (5 mg/l) (for 28 days) and hydralazine (80 mg/l) (for 28 days) and controlled hydralazine content drinking water (25 mg/l) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 276.6 g 7.4 23.4 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100807 2523
MW body weight nephrectomy (for 28 days) then control condition Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. body mass male 0 days 8 250.0 g 3.0 8.49 body weighing method 0.0 5/6 nephrectomy 28 days 100983 2561
MW body weight right nephrectomy (for 112 days) then reserpine (5 mg/l) (for 56 days) and hydralazine (80 mg/l) (for 56 days) and controlled hydralazine content drinking water (25 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 244.3 g 17.2 54.39 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100828 2523
MW body weight right nephrectomy (for 112 days) then captopril (30 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 320.6 g 15.0 47.43 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100829 2523
MW body weight right nephrectomy (for 112 days) then angiotensin II receptor antagonist (20 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 7 289.0 g 13.6 35.98 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100832 2523
MW body weight unilateral nephrectomy (for 70 days) then vehicle control condition Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 286.0 g 9.0 23.81 body measuring method 0.0 unx 70 days 101154 2581
MW body weight doxorubicin (2 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 314.0 g 18.0 47.62 body measuring method 0.0 doxorubicin 29 days 101156 2581
MW body weight nephrectomy (for 28 days) then enalapril (50 mg/l) (for 21 days) Anderson S, et al., J Clin Invest. 1986 Jun;77(6):1993-2000. body mass male 0 days 8 248.0 g 4.0 11.31 body weighing method 0.0 5/6 nephrectomy 28 days 100984 2561
MW body weight right nephrectomy (for 56 days) then angiotensin II receptor antagonist (20 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 7 254.9 g 14.1 37.31 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100804 2523
MW body weight unilateral nephrectomy (for 14 days) then puromycin aminonucleoside (100 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 6 224.0 g 9.0 22.05 body measuring method 0.0 unx 14 days 101141 2581
MW body weight unilateral nephrectomy (for 14 days) then vehicle control condition Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 260.0 g 6.0 15.87 body measuring method 0.0 unx 42 days 101146 2581
MW body weight doxorubicin (2 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 7 300.0 g 11.0 29.1 body measuring method 0.0 doxorubicin 17 days 101148 2581
MW body weight unilateral nephrectomy (for 70 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 6 213.0 g 17.0 41.64 body measuring method 0.0 unx 70 days 101153 2581
MW body weight right nephrectomy (for 84 days) then angiotensin II receptor antagonist (20 mg/l) (for 28 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 7 284.7 g 7.2 19.05 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 84 days 100825 2523
MW body weight right nephrectomy (for 112 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 6 283.2 g 19.9 48.74 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100827 2523
MW body weight right nephrectomy (for 112 days) then lisinopril (10 mg/kg/d) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 293.0 g 14.2 44.9 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100831 2523
MW body weight unilateral nephrectomy (for 42 days) then puromycin aminonucleoside (100 mg/kg) then puromycin aminonucleoside (40 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 6 237.0 g 12.0 29.39 body measuring method 0.0 unx 42 days 101145 2581
MW body weight right nephrectomy (for 56 days) then enalapril (20 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 9 280.5 g 1.1 3.3 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100802 2523
MW body weight right nephrectomy (for 56 days) then angiotensin II receptor antagonist (80 mg/l) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 5 257.0 g 6.1 13.64 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100805 2523
MW body weight right nephrectomy (for 112 days) then angiotensin II receptor antagonist (80 mg/l) (for 56 days) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 5 271.0 g 14.1 31.53 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 112 days 100833 2523
MW body weight right nephrectomy (for 56 days) then lisinopril (10 mg/kg/d) Kakinuma Y, et al., Kidney Int. 1992 Jul;42(1):46-55. body mass male 0 days 10 282.7 g 5.1 16.13 body weighing method 0.0 ~5/6 to 7/8 nephrectomy 56 days 100803 2523
MW body weight unilateral nephrectomy (for 14 days) and captopril (500 mg/l) (for 14 days) then puromycin aminonucleoside (100 mg/kg) Fogo A, et al., J Clin Invest. 1988 Jul;82(1):322-30. body mass male 0 days 5 232.0 g 6.0 13.42 body measuring method 0.0 unx 14 days 101143 2581